{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": ["IM"], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "34603599", "DateCompleted": {"Year": "2022", "Month": "01", "Day": "31"}, "DateRevised": {"Year": "2022", "Month": "01", "Day": "31"}, "Article": {"ArticleDate": [{"Year": "2021", "Month": "09", "Day": "23"}], "Language": ["eng"], "ELocationID": ["5876841", "10.1155/2021/5876841"], "Journal": {"ISSN": "1942-0994", "JournalIssue": {"Volume": "2021", "PubDate": {"Year": "2021"}}, "Title": "Oxidative medicine and cellular longevity", "ISOAbbreviation": "Oxid Med Cell Longev"}, "ArticleTitle": "SIRT5-Related Desuccinylation Modification Contributes to Quercetin-Induced Protection against Heart Failure and High-Glucose-Prompted Cardiomyocytes Injured through Regulation of Mitochondrial Quality Surveillance.", "Pagination": {"StartPage": "5876841", "MedlinePgn": "5876841"}, "Abstract": {"AbstractText": ["Myocardial fibrosis represents the primary pathological change associated with diabetic cardiomyopathy and heart failure, and it leads to decreased myocardial compliance with impaired cardiac diastolic and systolic function. Quercetin, an active ingredient in various medicinal plants, exerts therapeutic effects against cardiovascular diseases. Here, we investigate whether SIRT5- and IDH2-related desuccinylation is involved in the underlying mechanism of myocardial fibrosis in heart failure while exploring related therapeutic drugs for mitochondrial quality surveillance. Mouse models of myocardial fibrosis and heart failure, established by transverse aortic constriction (TAC), were administered with quercetin (50\u2009mg/kg) daily for 4 weeks. HL-1 cells were pretreated with quercetin and treated with high glucose (30\u2009mM) <i>in vitro</i>. Cardiac function, western blotting, quantitative PCR, enzyme-linked immunosorbent assay, and immunofluorescence analysis were employed to analyze mitochondrial quality surveillance, oxidative stress, and inflammatory response in myocardial cells, whereas IDH2 succinylation levels were detected using immunoprecipitation. Myocardial fibrosis and heart failure incidence increased after TAC, with abnormal cardiac ejection function. Following high-glucose treatment, HL-1 cell activity was inhibited, causing excess production of reactive oxygen species and inhibition of mitochondrial respiratory complex I/III activity and mitochondrial antioxidant enzyme activity, as well as increased oxidative stress and inflammatory response, imbalanced mitochondrial quality surveillance and homeostasis, and increased apoptosis. Quercetin inhibited myocardial fibrosis and improved cardiac function by increasing mitochondrial energy metabolism and regulating mitochondrial fusion/fission and mitochondrial biosynthesis while inhibiting the inflammatory response and oxidative stress injury. Additionally, TAC inhibited SIRT5 expression at the mitochondrial level and increased IDH2 succinylation. However, quercetin promoted the desuccinylation of IDH2 by increasing SIRT5 expression. Moreover, treatment with si-SIRT5 abolished the protective effect of quercetin on cell viability. Hence, quercetin may promote the desuccinylation of IDH2 through SIRT5, maintain mitochondrial homeostasis, protect mouse cardiomyocytes under inflammatory conditions, and improve myocardial fibrosis, thereby reducing the incidence of heart failure."], "CopyrightInformation": "Copyright \u00a9 2021 Xing Chang et al."}, "AuthorList": [{"Identifier": ["0000-0002-3788-9881"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Shandong University of Traditional Chinese Medicine, Jinan, Shandong 250355, China."}, {"Identifier": [], "Affiliation": "Guang'anmen Hospital, Chinese Academy of Traditional Chinese Medicine, Beijing 100053, China."}], "LastName": "Chang", "ForeName": "Xing", "Initials": "X"}, {"Identifier": ["0000-0002-7193-0585"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Shandong University of Traditional Chinese Medicine, Jinan, Shandong 250355, China."}], "LastName": "Zhang", "ForeName": "Tian", "Initials": "T"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "The First Affiliated Hospital, Guangzhou University of Chinese Medicine, Guangzhou 510405, China."}], "LastName": "Wang", "ForeName": "Junyan", "Initials": "J"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Shandong University of Traditional Chinese Medicine, Jinan, Shandong 250355, China."}], "LastName": "Liu", "ForeName": "Yan", "Initials": "Y"}, {"Identifier": ["0000-0002-1955-4412"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Shandong University of Traditional Chinese Medicine, Jinan, Shandong 250355, China."}], "LastName": "Yan", "ForeName": "Peizheng", "Initials": "P"}, {"Identifier": ["0000-0002-0633-2271"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Shandong University of Traditional Chinese Medicine, Jinan, Shandong 250355, China."}], "LastName": "Meng", "ForeName": "Qingyan", "Initials": "Q"}, {"Identifier": ["0000-0002-6235-2867"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Shandong University of Traditional Chinese Medicine, Jinan, Shandong 250355, China."}], "LastName": "Yin", "ForeName": "Yongtian", "Initials": "Y"}, {"Identifier": ["0000-0002-5123-9690"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Shandong University of Traditional Chinese Medicine, Jinan, Shandong 250355, China."}], "LastName": "Wang", "ForeName": "Shiyuan", "Initials": "S"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "United States", "MedlineTA": "Oxid Med Cell Longev", "NlmUniqueID": "101479826", "ISSNLinking": "1942-0994"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "NLR Family, Pyrin Domain-Containing 3 Protein"}, {"RegistryNumber": "0", "NameOfSubstance": "Protective Agents"}, {"RegistryNumber": "0", "NameOfSubstance": "Reactive Oxygen Species"}, {"RegistryNumber": "0", "NameOfSubstance": "SIRT5 protein, mouse"}, {"RegistryNumber": "9IKM0I5T1E", "NameOfSubstance": "Quercetin"}, {"RegistryNumber": "EC 3.5.1.-", "NameOfSubstance": "Sirtuins"}, {"RegistryNumber": "IY9XDZ35W2", "NameOfSubstance": "Glucose"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": ["drug effects"], "DescriptorName": "Cell Survival"}, {"QualifierName": [], "DescriptorName": "Disease Models, Animal"}, {"QualifierName": ["drug effects"], "DescriptorName": "Energy Metabolism"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Glucose"}, {"QualifierName": ["drug therapy", "metabolism", "pathology"], "DescriptorName": "Heart Failure"}, {"QualifierName": [], "DescriptorName": "Male"}, {"QualifierName": [], "DescriptorName": "Mice"}, {"QualifierName": [], "DescriptorName": "Mice, Inbred C57BL"}, {"QualifierName": ["drug effects", "metabolism"], "DescriptorName": "Mitochondria, Heart"}, {"QualifierName": ["cytology", "drug effects", "metabolism"], "DescriptorName": "Myocytes, Cardiac"}, {"QualifierName": ["metabolism"], "DescriptorName": "NLR Family, Pyrin Domain-Containing 3 Protein"}, {"QualifierName": ["drug effects"], "DescriptorName": "Oxidative Stress"}, {"QualifierName": ["pharmacology", "therapeutic use"], "DescriptorName": "Protective Agents"}, {"QualifierName": ["pharmacology", "therapeutic use"], "DescriptorName": "Quercetin"}, {"QualifierName": ["metabolism"], "DescriptorName": "Reactive Oxygen Species"}, {"QualifierName": ["metabolism"], "DescriptorName": "Sirtuins"}], "CoiStatement": "The authors declare that there is no conflict of interest regarding the publication of this paper."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Baman J. R., Ahmad F. S. Heart failure. JAMA . 2020;324(10):p. 1015. doi: 10.1001/jama.2020.13310.", "ArticleIdList": ["10.1001/jama.2020.13310", "32749448"]}, {"Citation": "Mohammed S. F., Hussain S., Mirzoyev S. A., Edwards W. D., Maleszewski J. J., Redfield M. M. Coronary microvascular rarefaction and myocardial fibrosis in heart failure with preserved ejection fraction. Circulation . 2015;131(6):550\u2013559. doi: 10.1161/CIRCULATIONAHA.114.009625.", "ArticleIdList": ["10.1161/CIRCULATIONAHA.114.009625", "PMC4324362", "25552356"]}, {"Citation": "Gy\u00f6ngy\u00f6si M., Winkler J., Ramos I., et al. Myocardial fibrosis: biomedical research from bench to bedside. European Journal of Heart Failure . 2017;19(2):177\u2013191. doi: 10.1002/ejhf.696.", "ArticleIdList": ["10.1002/ejhf.696", "PMC5299507", "28157267"]}, {"Citation": "Bacmeister L., Schwarzl M., Warnke S., et al. Inflammation and fibrosis in murine models of heart failure. Basic Research in Cardiology . 2019;114(3) doi: 10.1007/s00395-019-0722-5.", "ArticleIdList": ["10.1007/s00395-019-0722-5", "30887214"]}, {"Citation": "Paulus W. J., Tsch\u00f6pe C. A novel paradigm for heart failure with preserved ejection fraction: comorbidities drive myocardial dysfunction and remodeling through coronary microvascular endothelial inflammation. Journal of the American College of Cardiology . 2013;62(4):263\u2013271. doi: 10.1016/j.jacc.2013.02.092.", "ArticleIdList": ["10.1016/j.jacc.2013.02.092", "23684677"]}, {"Citation": "de Boer R. A., De Keulenaer G., Bauersachs J., et al. Towards better definition, quantification and treatment of fibrosis in heart failure. A scientific roadmap by the Committee of Translational Research of the Heart Failure Association (HFA) of the European Society of Cardiology. European Journal of Heart Failure . 2019;21(3):272\u2013285. doi: 10.1002/ejhf.1406.", "ArticleIdList": ["10.1002/ejhf.1406", "PMC6607480", "30714667"]}, {"Citation": "Li C., Ma Q., Toan S., Wang J., Zhou H., Liang J. SERCA overexpression reduces reperfusion-mediated cardiac microvascular damage through inhibition of the calcium/MCU/mPTP/necroptosis signaling pathways. Redox Biology . 2020;36:p. 101659. doi: 10.1016/j.redox.2020.101659.", "ArticleIdList": ["10.1016/j.redox.2020.101659", "PMC7395441", "32738788"]}, {"Citation": "Zhu H., Toan S., Mui D., Zhou H. Mitochondrial quality surveillance as a therapeutic target in myocardial infarction. Acta Physiologica (Oxford, England) . 2021;231(3):p. e13590. doi: 10.1111/apha.13590.", "ArticleIdList": ["10.1111/apha.13590", "33270362"]}, {"Citation": "Wang J., Zhu P., Li R., Ren J., Zhou H. Fundc1-dependent mitophagy is obligatory to ischemic preconditioning-conferred renoprotection in ischemic AKI via suppression of Drp1-mediated mitochondrial fission. Redox Biology . 2020;30:p. 101415. doi: 10.1016/j.redox.2019.101415.", "ArticleIdList": ["10.1016/j.redox.2019.101415", "PMC6940662", "31901590"]}, {"Citation": "Wang J., Zhu P., Li R., Ren J., Zhang Y., Zhou H. Bax inhibitor 1 preserves mitochondrial homeostasis in acute kidney injury through promoting mitochondrial retention of PHB2. Theranostics . 2020;10(1):384\u2013397. doi: 10.7150/thno.40098.", "ArticleIdList": ["10.7150/thno.40098", "PMC6929616", "31903127"]}, {"Citation": "Zhou H., Zhu P., Wang J., Toan S., Ren J. DNA-PKcs promotes alcohol-related liver disease by activating Drp 1-related mitochondrial fission and repressing FUNDC1-required mitophagy. Signal Transduction and Targeted Therapy . 2019;4 doi: 10.1038/s41392-019-0094-1.", "ArticleIdList": ["10.1038/s41392-019-0094-1", "PMC6895206", "31839999"]}, {"Citation": "Cho H. M., Ryu J. R., Jo Y., et al. Drp 1-Zip 1 interaction regulates mitochondrial quality surveillance system. Molecular Cell . 2019;73(2) doi: 10.1016/j.molcel.2018.11.009.", "ArticleIdList": ["10.1016/j.molcel.2018.11.009", "30581142"]}, {"Citation": "Zhou H., Ren J., Toan S., Mui D. Role of mitochondrial quality surveillance in myocardial infarction: from bench to bedside. Ageing Research Reviews . 2021;66:p. 101250. doi: 10.1016/j.arr.2020.101250.", "ArticleIdList": ["10.1016/j.arr.2020.101250", "33388396"]}, {"Citation": "Wang J., Toan S., Zhou H. Mitochondrial quality control in cardiac microvascular ischemia-reperfusion injury: new insights into the mechanisms and therapeutic potentials. Pharmacological Research . 2020;156:p. 104771. doi: 10.1016/j.phrs.2020.104771.", "ArticleIdList": ["10.1016/j.phrs.2020.104771", "32234339"]}, {"Citation": "Tan Y., Mui D., Toan S., Zhu P., Li R., Zhou H. SERCA overexpression improves mitochondrial quality control and attenuates cardiac microvascular ischemia-reperfusion injury. Molecular Therapy Nucleic Acids . 2020;22:696\u2013707. doi: 10.1016/j.omtn.2020.09.013.", "ArticleIdList": ["10.1016/j.omtn.2020.09.013", "PMC7585837", "33230467"]}, {"Citation": "Gibb A. A., Lazaropoulos M. P., Elrod J. W. Myofibroblasts and fibrosis: mitochondrial and metabolic control of cellular differentiation. Circulation Research . 2020;127(3):427\u2013447. doi: 10.1161/CIRCRESAHA.120.316958.", "ArticleIdList": ["10.1161/CIRCRESAHA.120.316958", "PMC7982967", "32673537"]}, {"Citation": "Zhu H., Tan Y., Du W., et al. Phosphoglycerate mutase 5 exacerbates cardiac ischemia-reperfusion injury through disrupting mitochondrial quality control. Redox Biology . 2021;38:p. 101777. doi: 10.1016/j.redox.2020.101777.", "ArticleIdList": ["10.1016/j.redox.2020.101777", "PMC7658715", "33166869"]}, {"Citation": "Kenny H. C., Abel E. D. Heart failure in type 2 diabetes mellitus. Circulation Research . 2019;124(1):121\u2013141. doi: 10.1161/CIRCRESAHA.118.311371.", "ArticleIdList": ["10.1161/CIRCRESAHA.118.311371", "PMC6447311", "30605420"]}, {"Citation": "McHugh K., DeVore A. D., Wu J., et al. Heart Failure With Preserved Ejection Fraction and Diabetes: Journal of the American College of Cardiology . 2019;73(5):602\u2013611. doi: 10.1016/j.jacc.2018.11.033.", "ArticleIdList": ["10.1016/j.jacc.2018.11.033", "30732715"]}, {"Citation": "Lukey M. J., Greene K. S., Cerione R. A. Lysine succinylation and SIRT5 couple nutritional status to glutamine catabolism. Molecular & Cellular Oncology . 2020;7(3) doi: 10.1080/23723556.2020.1735284.", "ArticleIdList": ["10.1080/23723556.2020.1735284", "PMC7199738", "32391426"]}, {"Citation": "Chen X.\u2010. F., Tian M.\u2010. X., Sun R.\u2010. Q., et al. SIRT5 inhibits peroxisomal ACOX1 to prevent oxidative damage and is downregulated in liver cancer. EMBO Reports . 2018;19(5) doi: 10.15252/embr.201745124.", "ArticleIdList": ["10.15252/embr.201745124", "PMC5934778", "29491006"]}, {"Citation": "Xu L., Che X., Wu Y., et al. SIRT5 as a biomarker for response to anthracycline-taxane-based neoadjuvant chemotherapy in triple-negative breast cancer. Oncology Reports . 2018;39(5):2315\u20132323. doi: 10.3892/or.2018.6319.", "ArticleIdList": ["10.3892/or.2018.6319", "29565454"]}, {"Citation": "Boylston J. A., Sun J., Chen Y., Gucek M., Sack M. N., Murphy E. Characterization of the cardiac succinylome and its role in ischemia- reperfusion injury. Journal of Molecular and Cellular Cardiology . 2015;88:73\u201381. doi: 10.1016/j.yjmcc.2015.09.005.", "ArticleIdList": ["10.1016/j.yjmcc.2015.09.005", "PMC4780049", "26388266"]}, {"Citation": "Chen L., Wang H., Gao F., et al. Functional genetic variants in the _SIRT5_ gene promoter in acute myocardial infarction. Gene . 2018;675:233\u2013239. doi: 10.1016/j.gene.2018.07.010.", "ArticleIdList": ["10.1016/j.gene.2018.07.010", "29981421"]}, {"Citation": "Polletta L., Vernucci E., Carnevale I., et al. SIRT5 regulation of ammonia-induced autophagy and mitophagy. Autophagy . 2015;11(2):253\u2013270. doi: 10.1080/15548627.2015.1009778.", "ArticleIdList": ["10.1080/15548627.2015.1009778", "PMC4502726", "25700560"]}, {"Citation": "Kim H., Lee J. H., Park J. W. IDH2 deficiency exacerbates acetaminophen hepatotoxicity in mice via mitochondrial dysfunction-induced apoptosis. Biochimica et Biophysica Acta Molecular Basis of Disease . 2019;1865(9):2333\u20132341. doi: 10.1016/j.bbadis.2019.05.012.", "ArticleIdList": ["10.1016/j.bbadis.2019.05.012", "31121248"]}, {"Citation": "Chang X., Zhang T., Meng Q. Quercetin Improves Cardiomyocyte Vulnerability to Hypoxia by Regulating SIRT1/TMBIM6-Related Mitophagy and Endoplasmic Reticulum Stress. Oxidative Medicine and Cellular Longevity . 2021;2021:14. doi: 10.1155/2021/5529913.5529913", "ArticleIdList": ["10.1155/2021/5529913", "PMC8024107", "33859776"]}, {"Citation": "Wang L., Tan A., An X., Xia Y., Xie Y. Quercetin dihydrate inhibition of cardiac fibrosis induced by angiotensin II in vivo and in vitro. Biomedicine & Pharmacotherapy . 2020;127:p. 110205. doi: 10.1016/j.biopha.2020.110205.", "ArticleIdList": ["10.1016/j.biopha.2020.110205", "32403046"]}, {"Citation": "Gao W., Zhou Z., Liang B., et al. Inhibiting receptor of advanced glycation end products attenuates pressure overload-induced cardiac dysfunction by preventing excessive autophagy. Frontiers in Physiology . 2018;9 doi: 10.3389/fphys.2018.01333.", "ArticleIdList": ["10.3389/fphys.2018.01333", "PMC6165873", "30319444"]}, {"Citation": "Samokhvalov V., Jamieson K. L., Vriend J., Quan S., Seubert J. M. CYP epoxygenase metabolites of docosahexaenoic acid protect HL-1 cardiac cells against LPS-induced cytotoxicity through SIRT1. Cell Death Discovery . 2015;1(1) doi: 10.1038/cddiscovery.2015.54.", "ArticleIdList": ["10.1038/cddiscovery.2015.54", "PMC4864499", "27182450"]}, {"Citation": "Trindade F., Vitorino R., Leite-Moreira A., Falc\u00e3o-Pires I. Pericardial fluid: an underrated molecular library of heart conditions and a potential vehicle for cardiac therapy. Basic Research in Cardiology . 2019;114(2) doi: 10.1007/s00395-019-0716-3.", "ArticleIdList": ["10.1007/s00395-019-0716-3", "30659359"]}, {"Citation": "Xin T., Lv W., Liu D., Jing Y., Hu F. Opa 1 reduces hypoxia-induced cardiomyocyte death by improving mitochondrial quality control. Frontiers in Cell and Development Biology . 2020;8 doi: 10.3389/fcell.2020.00853.", "ArticleIdList": ["10.3389/fcell.2020.00853", "PMC7483501", "32984338"]}, {"Citation": "Zhong Z., Liang S., Sanchez-Lopez E., et al. New mitochondrial DNA synthesis enables NLRP3 inflammasome activation. Nature . 2018;560(7717):198\u2013203. doi: 10.1038/s41586-018-0372-z.", "ArticleIdList": ["10.1038/s41586-018-0372-z", "PMC6329306", "30046112"]}, {"Citation": "Zhong Z., Umemura A., Sanchez-Lopez E., et al. NF-\u03baB restricts inflammasome activation via elimination of damaged mitochondria. Cell . 2016;164(5):896\u2013910. doi: 10.1016/j.cell.2015.12.057.", "ArticleIdList": ["10.1016/j.cell.2015.12.057", "PMC4769378", "26919428"]}, {"Citation": "Manfredi A. A., Rovere-Querini P. The Mitochondrion-A Trojan horse that kicks off inflammation? The New England Journal of Medicine . 2010;362(22):2132\u20132134. doi: 10.1056/NEJMcibr1003521.", "ArticleIdList": ["10.1056/NEJMcibr1003521", "20519686"]}, {"Citation": "Chang X., Zhao Z., Zhang W., et al. Natural antioxidants improve the vulnerability of cardiomyocytes and vascular endothelial cells under stress conditions: a focus on mitochondrial quality control. Oxidative Medicine and Cellular Longevity . 2021;2021:27. doi: 10.1155/2021/6620677.6620677", "ArticleIdList": ["10.1155/2021/6620677", "PMC7847351", "33552385"]}, {"Citation": "Yang J., Savvatis K., Kang J. S., et al. Targeting LOXL2 for cardiac interstitial fibrosis and heart failure treatment. Nature Communications . 2016;7(1) doi: 10.1038/ncomms13710.", "ArticleIdList": ["10.1038/ncomms13710", "PMC5171850", "27966531"]}, {"Citation": "Xu G. R., Zhang C., Yang H. X., et al. Modified citrus pectin ameliorates myocardial fibrosis and inflammation via suppressing galectin-3 and TLR4/MyD88/NF-\u03baB signaling pathway. Biomedicine & Pharmacotherapy . 2020;126:p. 110071. doi: 10.1016/j.biopha.2020.110071.", "ArticleIdList": ["10.1016/j.biopha.2020.110071", "32172066"]}, {"Citation": "Wang J., Toan S., Zhou H. New insights into the role of mitochondria in cardiac microvascular ischemia/reperfusion injury. Angiogenesis . 2020;23(3):299\u2013314. doi: 10.1007/s10456-020-09720-2.", "ArticleIdList": ["10.1007/s10456-020-09720-2", "32246225"]}, {"Citation": "Balakumar P., Maung U. K., Jagadeesh G. Prevalence and prevention of cardiovascular disease and diabetes mellitus. Pharmacological Research . 2016;113(Part A):600\u2013609. doi: 10.1016/j.phrs.2016.09.040.", "ArticleIdList": ["10.1016/j.phrs.2016.09.040", "27697647"]}, {"Citation": "Jia G., Hill M. A., Sowers J. R. Diabetic cardiomyopathy: an update of mechanisms contributing to this clinical entity. Circulation Research . 2018;122(4):624\u2013638. doi: 10.1161/CIRCRESAHA.117.311586.", "ArticleIdList": ["10.1161/CIRCRESAHA.117.311586", "PMC5819359", "29449364"]}, {"Citation": "Hu L., Ding M., Tang D., et al. Targeting mitochondrial dynamics by regulating Mfn 2 for therapeutic intervention in diabetic cardiomyopathy. Theranostics . 2019;9(13):3687\u20133706. doi: 10.7150/thno.33684.", "ArticleIdList": ["10.7150/thno.33684", "PMC6587356", "31281507"]}, {"Citation": "Kovacic J. C., Castellano J. M., Farkouh M. E., Fuster V. The relationships between cardiovascular disease and diabetes: focus on pathogenesis. Endocrinology and Metabolism Clinics of North America . 2014;43(1):41\u201357. doi: 10.1016/j.ecl.2013.09.007.", "ArticleIdList": ["10.1016/j.ecl.2013.09.007", "24582091"]}, {"Citation": "Norhammar A., Schenck-Gustafsson K. Type 2 diabetes and cardiovascular disease in women. Diabetologia . 2013;56(1):1\u20139. doi: 10.1007/s00125-012-2694-y.", "ArticleIdList": ["10.1007/s00125-012-2694-y", "22945305"]}, {"Citation": "Maritim A. C., Sanders R. A., Watkins J. B., 3rd Diabetes, oxidative stress, and antioxidants: a review. Journal of Biochemical and Molecular Toxicology . 2003;17(1):24\u201338. doi: 10.1002/jbt.10058.", "ArticleIdList": ["10.1002/jbt.10058", "12616644"]}, {"Citation": "Svegliati S., Spadoni T., Moroncini G., Gabrielli A. NADPH oxidase, oxidative stress and fibrosis in systemic sclerosis. Free Radical Biology & Medicine . 2018;125:90\u201397. doi: 10.1016/j.freeradbiomed.2018.04.554.", "ArticleIdList": ["10.1016/j.freeradbiomed.2018.04.554", "29694853"]}, {"Citation": "Chang X., Zhang T., Zhang W., Zhao Z., Sun J. Natural drugs as a treatment strategy for cardiovascular disease through the regulation of oxidative stress. Oxidative Medicine and Cellular Longevity . 2020;2020:20. doi: 10.1155/2020/5430407.", "ArticleIdList": ["10.1155/2020/5430407", "PMC7537704", "33062142"]}, {"Citation": "Magar R. T., Sohng J. K. A review on structure, modifications and structure-activity relation of quercetin and its derivatives. Journal of Microbiology and Biotechnology . 2020;30(1):11\u201320. doi: 10.4014/jmb.1907.07003.", "ArticleIdList": ["10.4014/jmb.1907.07003", "PMC9728256", "31752056"]}, {"Citation": "Latypova G. M., Bychenkova M. A., Katayev V. A., et al. Composition and cardioprotective effects of _Primula veris_ L. solid herbal extract in experimental chronic heart failure. Phytomedicine: International Journal of Phytotherapy and Phytopharmacology . 2019;54:17\u201326. doi: 10.1016/j.phymed.2018.09.015.", "ArticleIdList": ["10.1016/j.phymed.2018.09.015", "30668367"]}, {"Citation": "Hussain T., Tan B., Yin Y., Blachier F., Tossou M. C., Rahu N. Oxidative stress and inflammation: what polyphenols can do for us? Oxidative Medicine and Cellular Longevity . 2016;2016:9. doi: 10.1155/2016/7432797.", "ArticleIdList": ["10.1155/2016/7432797", "PMC5055983", "27738491"]}, {"Citation": "Guzik T. J., Touyz R. M. Oxidative stress, inflammation, and vascular aging in hypertension. Hypertension (Dallas, Tex: 1979) . 2017;70(4):660\u2013667. doi: 10.1161/HYPERTENSIONAHA.117.07802.", "ArticleIdList": ["10.1161/HYPERTENSIONAHA.117.07802", "28784646"]}, {"Citation": "Bagul P. K., Deepthi N., Sultana R., Banerjee S. K. Resveratrol ameliorates cardiac oxidative stress in diabetes through deacetylation of NFkB-p65 and histone 3. The Journal of Nutritional Biochemistry . 2015;26(11):1298\u20131307. doi: 10.1016/j.jnutbio.2015.06.006.", "ArticleIdList": ["10.1016/j.jnutbio.2015.06.006", "26298192"]}, {"Citation": "Chang X., Zhang W., Zhao Z., et al. Regulation of mitochondrial quality control by natural drugs in the treatment of cardiovascular diseases: potential and advantages. Frontiers in Cell and Development Biology . 2020;8 doi: 10.3389/fcell.2020.616139.", "ArticleIdList": ["10.3389/fcell.2020.616139", "PMC7793684", "33425924"]}, {"Citation": "Kim Y.-R., Baek J.-I., Kim S. H., et al. Therapeutic potential of the mitochondria-targeted antioxidant MitoQ in mitochondrial-ROS induced sensorineural hearing loss caused by _Idh2_ deficiency. Redox Biology . 2019;20:544\u2013555. doi: 10.1016/j.redox.2018.11.013.", "ArticleIdList": ["10.1016/j.redox.2018.11.013", "PMC6279977", "30508699"]}, {"Citation": "Han S. J., Choi H. S., Kim J. I., Park J. W., Park K. M. IDH2 deficiency increases the liver susceptibility to ischemia-reperfusion injury via increased mitochondrial oxidative injury. Redox Biology . 2018;14:142\u2013153. doi: 10.1016/j.redox.2017.09.003.", "ArticleIdList": ["10.1016/j.redox.2017.09.003", "PMC5608561", "28938192"]}, {"Citation": "Cha H., Lee S., Hwan Kim S., et al. Increased susceptibility of IDH2-deficient mice to dextran sodium sulfate- induced colitis. Redox Biology . 2017;13:32\u201338. doi: 10.1016/j.redox.2017.05.009.", "ArticleIdList": ["10.1016/j.redox.2017.05.009", "PMC5447514", "28554049"]}, {"Citation": "Ku H. J., Ahn Y., Lee J. H., Park K. M., Park J. W. IDH2 deficiency promotes mitochondrial dysfunction and cardiac hypertrophy in mice. Free Radical Biology & Medicine . 2015;80:84\u201392. doi: 10.1016/j.freeradbiomed.2014.12.018.", "ArticleIdList": ["10.1016/j.freeradbiomed.2014.12.018", "25557279"]}, {"Citation": "You W., Zheng W., Weiss S., Chua K. F., Steegborn C. Structural basis for the activation and inhibition of sirtuin 6 by quercetin and its derivatives. Scientific Reports . 2019;9(1):p. 19176. doi: 10.1038/s41598-019-55654-1.", "ArticleIdList": ["10.1038/s41598-019-55654-1", "PMC6914789", "31844103"]}, {"Citation": "Heger V., Tyni J., Hunyadi A., Hor\u00e1kov\u00e1 L., Lahtela-Kakkonen M., Rahnasto-Rilla M. Quercetin based derivatives as sirtuin inhibitors. Biomedicine & Pharmacotherapy . 2019;111:1326\u20131333. doi: 10.1016/j.biopha.2019.01.035.", "ArticleIdList": ["10.1016/j.biopha.2019.01.035", "30841446"]}, {"Citation": "Zhou L., Wang F., Sun R., et al. SIRT5 promotes IDH2 desuccinylation and G6PD deglutarylation to enhance cellular antioxidant defense. EMBO Reports . 2016;17(6):811\u2013822. doi: 10.15252/embr.201541643.", "ArticleIdList": ["10.15252/embr.201541643", "PMC5278614", "27113762"]}], "ReferenceList": []}], "History": [{"Year": "2021", "Month": "4", "Day": "14"}, {"Year": "2021", "Month": "7", "Day": "27"}, {"Year": "2021", "Month": "8", "Day": "13"}, {"Year": "2021", "Month": "10", "Day": "4", "Hour": "6", "Minute": "1"}, {"Year": "2021", "Month": "10", "Day": "5", "Hour": "6", "Minute": "0"}, {"Year": "2022", "Month": "2", "Day": "1", "Hour": "6", "Minute": "0"}, {"Year": "2021", "Month": "9", "Day": "23"}], "PublicationStatus": "epublish", "ArticleIdList": ["34603599", "PMC8486530", "10.1155/2021/5876841"]}}], "PubmedBookArticle": []}